Institutional Ownership Fate Therapeutics Inc (FATE)
This table provides information about the institutional ownership of Fate Therapeutics Inc (FATE). We have compiled data on the 175 institutions that hold shares in the stock, with a total of 115 Million shares, which have been reported (via 13F filing form) to have a value of $191 Million.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Redmile Group, LLC
San Francisco, CA |
Nov 14, 2024 Q3 2024 |
13,169,057
shares
|
$22.1 Million
3.01% of portfolio
|
Q4 2023
Added 0.34%
|
|
|
Vanguard Group Inc
Valley Forge, PA |
Nov 13, 2024 Q3 2024 |
10,404,123
shares
|
$17.5 Million
0.0% of portfolio
|
Q3 2024
Reduced 1.57%
|
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
10,116,106
shares
|
$17 Million
0.0% of portfolio
|
Q2 2024
Added 11.17%
|
|
|
Deep Track Capital, LP
Greenwich, CT |
Nov 14, 2024 Q3 2024 |
5,572,607
shares
|
$9.36 Million
0.72% of portfolio
|
Q1 2024
New holding
|
|
|
State Street Corp
Boston, MA |
Nov 14, 2024 Q3 2024 |
5,252,974
shares
|
$8.82 Million
0.0% of portfolio
|
Q3 2024
Reduced 1.61%
|
|
|
Boxer Capital, LLC
San Diego, CA |
Nov 14, 2024 Q3 2024 |
4,960,910
shares
|
$8.33 Million
0.92% of portfolio
|
Q3 2024
Reduced 39.62%
|
|
|
Bellevue Group Ag
Kuesnacht, V8 |
Nov 14, 2024 Q3 2024 |
4,839,779
shares
|
$8.13 Million
0.29% of portfolio
|
Q1 2024
Reduced 0.24%
|
|
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
Nov 14, 2024 Q3 2024 |
4,282,077
shares
|
$7.19 Million
0.0% of portfolio
|
Q3 2024
Reduced 4.59%
|
|
|
Deerfield Management Company, L.P. (Series C)
New York, NY |
Nov 14, 2024 Q3 2024 |
3,555,871
shares
|
$5.97 Million
0.23% of portfolio
|
Q2 2024
Added 62.34%
|
|
|
Johnson & Johnson
New Brunswick, NJ |
Nov 13, 2024 Q3 2024 |
3,379,064
shares
|
$5.68 Million
3.77% of portfolio
|
Q3 2021
New holding
|
|
|
D. E. Shaw & Co., Inc.
New York, NY |
Nov 14, 2024 Q3 2024 |
3,377,650
shares
|
$5.67 Million
0.01% of portfolio
|
Q3 2024
Reduced 17.17%
|
|
|
Woodline Partners LP
San Francisco, CA |
Nov 14, 2024 Q3 2024 |
3,065,747
shares
|
$5.15 Million
0.1% of portfolio
|
Q3 2024
Added 205.96%
|
|
|
Morgan Stanley
New York, NY |
Nov 14, 2024 Q3 2024 |
3,063,421
shares
|
$5.15 Million
0.0% of portfolio
|
Q3 2024
Reduced 2.69%
|
|
|
Baker Bros. Advisors LP
New York, NY |
Nov 14, 2024 Q3 2024 |
2,997,772
shares
|
$5.04 Million
0.11% of portfolio
|
Q2 2024
Added 64.88%
|
|
|
Goldman Sachs Group Inc
New York, NY |
Nov 14, 2024 Q3 2024 |
2,823,403
shares
|
$4.74 Million
0.0% of portfolio
|
Q3 2024
Added 20.22%
|
|
|
Dimensional Fund Advisors LP
Austin, TX |
Nov 07, 2024 Q3 2024 |
2,619,017
shares
|
$4.4 Million
0.0% of portfolio
|
Q3 2024
Added 22.94%
|
|
|
Assenagon Asset Management S.A.
|
Oct 23, 2024 Q3 2024 |
2,434,198
shares
|
$4.09 Million
0.02% of portfolio
|
Q3 2024
Reduced 5.46%
|
|
|
Geode Capital Management, LLC
Boston, MA |
Nov 12, 2024 Q3 2024 |
2,258,246
shares
|
$3.79 Million
0.0% of portfolio
|
Q3 2024
Added 0.48%
|
|
|
Jpmorgan Chase & CO
New York, NY |
Nov 08, 2024 Q3 2024 |
1,837,304
shares
|
$3.09 Million
0.0% of portfolio
|
Q3 2024
Added 18.21%
|
|
|
Vestal Point Capital, LP
New York, NY |
Nov 14, 2024 Q3 2024 |
1,685,000
shares
|
$2.83 Million
0.45% of portfolio
|
Q3 2024
Reduced 15.75%
|
|
|
Orbimed Advisors LLC
San Diego, CA |
Nov 14, 2024 Q3 2024 |
1,680,580
shares
|
$2.82 Million
0.14% of portfolio
|
Q3 2024
Added 24.0%
|
|
|
Acadian Asset Management LLC
Boston, MA |
Nov 12, 2024 Q3 2024 |
1,602,120
shares
|
$2.69 Million
0.02% of portfolio
|
Q3 2024
Reduced 20.25%
|
|
|
Jacobs Levy Equity Management, Inc
Florham Park, NJ |
Nov 14, 2024 Q3 2024 |
1,587,900
shares
|
$2.67 Million
0.02% of portfolio
|
Q3 2024
Reduced 6.28%
|
|
|
Superstring Capital Management LP
New York, NY |
Nov 14, 2024 Q3 2024 |
1,466,934
shares
|
$2.46 Million
4.49% of portfolio
|
Q3 2024
Added 194.94%
|
|
|
Pictet Asset Management Sa
Geneva 73, V8 |
Aug 10, 2023 Q2 2023 |
1,090,260
shares
|
$1.83 Million
0.01% of portfolio
|
Q2 2023
Reduced 9.09%
|